These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2435334)

  • 1. Preparation and disposition of asialofetuin-labelled liposome.
    Tsuchiya S; Aramaki Y; Hara T; Hosoi K; Okada A
    Biopharm Drug Dispos; 1986; 7(6):549-58. PubMed ID: 2435334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein.
    Hara T; Aramaki Y; Tsuchiya S; Hosoi K; Okada A
    Biopharm Drug Dispos; 1987; 8(4):327-39. PubMed ID: 2441770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.
    Hara T; Kuwasawa H; Aramaki Y; Takada S; Koike K; Ishidate K; Kato H; Tsuchiya S
    Biochim Biophys Acta; 1996 Jan; 1278(1):51-8. PubMed ID: 8611607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective incorporation of asialofetuin into hepatocyte of rat.
    Aramaki Y; Inaba A; Tsuchiya S
    Biopharm Drug Dispos; 1985; 6(4):389-400. PubMed ID: 2417637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of asialofetuin-labeled liposomes with encapsulated human interferon-gamma and their uptake by isolated rat hepatocytes.
    Ishihara H; Hara T; Aramaki Y; Tsuchiya S; Hosoi K
    Pharm Res; 1990 May; 7(5):542-6. PubMed ID: 1694992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
    Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
    Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular degradation of asialoglycoproteins in hepatocytes starts in a subgroup of lysosomes.
    Berg T; Ford T; Kindberg G; Blomhoff R; Drevon C
    Exp Cell Res; 1985 Feb; 156(2):570-4. PubMed ID: 2578406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins and peptides bound to long-circulating liposomes.
    Maruyama K; Mori A; Bhadra S; Subbiah MT; Huang L
    Biochim Biophys Acta; 1991 Nov; 1070(1):246-52. PubMed ID: 1721540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo.
    Spanjer HH; Scherphof GL
    Biochim Biophys Acta; 1983 Sep; 734(1):40-7. PubMed ID: 6193809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression.
    Dasí F; Benet M; Crespo J; Crespo A; Aliño SF
    J Mol Med (Berl); 2001 May; 79(4):205-12. PubMed ID: 11409712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization, stability and in-vivo distribution of asialofetuin glycopeptide incorporating DSPC/CHOL liposomes prepared by mild cholate incubation.
    Kallinteri P; Liao WY; Antimisiaris SG; Hwang KH
    J Drug Target; 2001 Apr; 9(2):155-68. PubMed ID: 11697109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.
    Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
    Gene; 1995 Jul; 159(2):167-74. PubMed ID: 7542617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes.
    Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
    Gene Ther; 1995 Dec; 2(10):784-8. PubMed ID: 8750019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for in vivo hepatic uptake of a galactose-terminated glycoprotein in fish (Salmo alpinus L.).
    Dannevig BH; Tolleshaug H; Berg T
    Biochim Biophys Acta; 1981 Nov; 677(3-4):501-5. PubMed ID: 6170347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of mitomycin C to the liver by the use of asialofetuin as a carrier.
    Kaneo Y; Tanaka T; Iguchi S
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):999-1003. PubMed ID: 1716529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lysosomal inhibitors on 125I-insulin and 125I-asialofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes.
    Ward WF; Moss AL
    Diabetes; 1985 May; 34(5):446-51. PubMed ID: 2580748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalent interaction between asialofetuin and plasma membrane preparations from the rat liver.
    Debanne MT; Regoeczi E; Hatton MW
    Can J Biochem; 1980 Dec; 58(12):1414-20. PubMed ID: 6166359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monensin inhibits receptor-mediated endocytosis of asialoglycoproteins in rat hepatocytes.
    Berg T; Blomhoff R; Naess L; Tolleshaug H; Drevon CA
    Exp Cell Res; 1983 Oct; 148(2):319-30. PubMed ID: 6195005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of asialoglycoproteins in cultured rat hepatocytes: evidence for receptor mediated uptake and degradation which is not feed-back regulated.
    Drevon CA; Tolleshaug H; Carlander B; Berg T
    Int J Biochem; 1983; 15(6):827-33. PubMed ID: 6190689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of leupeptin on the intracellular degradation of asialofetuin in isolated rat hepatocytes.
    Berg T; Tolleshaug H
    Acta Biol Med Ger; 1981; 40(10-11):1599-602. PubMed ID: 6177139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.